Lead Product(s): Induced pluripotent stem cells
Therapeutic Area: Neurology
Highest Development Status: Undisclosed Product Type: Large molecule
Partner/Sponsor/Collaborator: Bristol-Myers Squibb
Deal Size: $6.0 million Upfront Cash: Undisclosed
Deal Type: Collaboration January 07, 2020
This partnership pursues an innovative approach to identifying and creating novel medicines using several of Evotec's technology technologies in tandem with the human iPSC-based platform.